Lyell Immunopharma
Developing next-generation T-cell therapies for patients with solid tumors.
biotech
Company facts
- Founded
- 2018
- Employees
- 300
- Headquarters
- United States
- Type
- Public
- Listed
- NASDAQ: LYEL
Open positions
1 job
2 views 2 months ago
Associate Director, Clinical Development Program Management
Open 63d North America
United States
Using living cells to treat – and sometimes even cure – cancer is one of the most dramatic advances in modern medicine. Patients with hematologic malignancies have been successfully treated with cell therapies.…
AI Asana GCP Microsoft Project Monday.com +2 skills